数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
刘峻岭 Co-founder, Co-Chairman and Chief Executive Officer 58 未披露 3711.54 2023-04-28
于刚 Co-founder and Co-Chairman 63 未披露 3600.00 2023-04-28
Nee Chuan Teo Independent Director 52 未披露 未持股 2023-04-28
Jian Sun Independent Director 58 未披露 未持股 2023-04-28
Leon Lian Yong Chen Director 60 未披露 726.09 2023-04-28
Jun Luo Independent Director 55 未披露 未持股 2023-04-28

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
刘峻岭 Co-founder, Co-Chairman and Chief Executive Officer 58 未披露 3711.54 2023-04-28

董事简历

中英对照 |  中文 |  英文
刘峻岭

刘峻岭先生,自2015年1月起担任汽车之家独立董事。刘先生是1号店的共同创始人和首席执行官,一个领先的在线食品杂货零售商在中国。在建立1号店2008刘先生是戴尔中国大陆和香港的联席总裁。在这之前,他是Avaya中国董事总经理。刘先生收到他的硕士学位,澳大利亚佛林德斯大学国际工商管理。刘峻岭先生,于2018年9月14日获委任为华领医药独立非执行董事。


Junling Liu,has served as Autohome Inc. independent director since January 2015. Mr. Liu is the co-founder, chairman and chief executive officer of 111, Inc. (Nasdaq: YI), an online healthcare cloud service provider. He co-founded and served as chief executive officer of YHD.com from 2008 to 2015. Prior to founding YHD.com, Mr. Liu served as the global vice president and president for mainland China and Hong Kong at Dell Inc. from 2006 to 2007. He also held various executive positions at internationally renowned technology companies such as Avaya (China) Communication Co., Ltd. Mr. Liu received his bachelor's degree in education from Flinders University in Australia and master's degree in international business administration from Flinders University.
刘峻岭先生,自2015年1月起担任汽车之家独立董事。刘先生是1号店的共同创始人和首席执行官,一个领先的在线食品杂货零售商在中国。在建立1号店2008刘先生是戴尔中国大陆和香港的联席总裁。在这之前,他是Avaya中国董事总经理。刘先生收到他的硕士学位,澳大利亚佛林德斯大学国际工商管理。刘峻岭先生,于2018年9月14日获委任为华领医药独立非执行董事。
Junling Liu,has served as Autohome Inc. independent director since January 2015. Mr. Liu is the co-founder, chairman and chief executive officer of 111, Inc. (Nasdaq: YI), an online healthcare cloud service provider. He co-founded and served as chief executive officer of YHD.com from 2008 to 2015. Prior to founding YHD.com, Mr. Liu served as the global vice president and president for mainland China and Hong Kong at Dell Inc. from 2006 to 2007. He also held various executive positions at internationally renowned technology companies such as Avaya (China) Communication Co., Ltd. Mr. Liu received his bachelor's degree in education from Flinders University in Australia and master's degree in international business administration from Flinders University.
于刚

于刚,是111,Inc.联合创始人,自2015年起担任111,Inc.执行董事长。自2018年9月起,于博士担任111,Inc.联合董事长。他是许多著名国际奖项的获得者,包括INFORMS颁发的2002年Franz Edelman管理科学成就奖和POMS颁发的2012年Martin K. Starr卓越生产和运营管理实践奖。于博士是YHD.com(中国领先的电子商务公司)的联合创始人和董事长。于博士目前担任Midea Group Co., Ltd.(深圳证券交易所代码:000333),LightInTheBox控股有限公司(纽约证券交易所代码:LITB)和Chindata Group Holdings Limited(NASDAQ:CD)的董事,并担任Zall集团(02098.HK)董事会联席主席。在创立YHD.com之前,于博士从2006年到2007年担任Dell Inc.全球采购副总裁,从2004年到2006年担任Amazon.com全球供应链副总裁。在亚马逊之前,于博士从1989年到2004年担任the University of Texas at Austin McCombs School of Business的讲座教授。他于1982年获得武汉大学理学学士学位,1986年获得Cornell University物理学硕士学位,1990年获得Wharton School of the University of Pennsylvania决策科学博士学位。于博士自2019年起担任the Wharton School of the University of Pennsylvania的监管委员会成员。于博士出版了6本专著和80多篇期刊文章。于博士还持有三项与航空公司优化解决方案相关的美国专利。


Gang Yu,is 111, Inc. co-founder and has served as 111, Inc. executive chairman since 2015. Since September 2018, Dr. Yu has served as 111, Inc. co-chairman. He is a recipient of numerous prestigious international awards, including the 2002 Franz Edelman Management Science Achievement Award from INFORMS and the 2012 Martin K. Starr Excellence in Production and Operations Management Practice Award from POMS. Dr. Yu co-founded and served as chairman of YHD.com, a leading e-commerce company in China. Dr. Yu currently serves as a director of Midea Group Co., Ltd. (SZSE: 000333), LightInTheBox Holding Co., Ltd. (NYSE: LITB) and Chindata Group Holdings Limited (NASDAQ: CD), and as the co-chairman of the board of Zall Group (02098.HK). Prior to founding YHD.com, Dr. Yu served as the vice president of Worldwide Procurement at Dell Inc. from 2006 to 2007 and the vice president of Worldwide Supply Chain at Amazon.com from 2004 to 2006. Before Amazon, Dr. Yu was the chair professor at McCombs School of Business at The University of Texas at Austin from 1989 to 2004. Dr. Yu received his bachelor's degree in science from Wuhan University in 1982, master's degree in physics from Cornell University in 1986 and Ph.D. degree in decision sciences from The Wharton School of the University of Pennsylvania in 1990. Dr. Yu has been a member of the Board of Overseers of The Wharton School of the University of Pennsylvania since 2019. Dr. Yu has published 6 books and over 80 journal articles. Dr. Yu also holds three U.S. patents related to airline optimization solutions.
于刚,是111,Inc.联合创始人,自2015年起担任111,Inc.执行董事长。自2018年9月起,于博士担任111,Inc.联合董事长。他是许多著名国际奖项的获得者,包括INFORMS颁发的2002年Franz Edelman管理科学成就奖和POMS颁发的2012年Martin K. Starr卓越生产和运营管理实践奖。于博士是YHD.com(中国领先的电子商务公司)的联合创始人和董事长。于博士目前担任Midea Group Co., Ltd.(深圳证券交易所代码:000333),LightInTheBox控股有限公司(纽约证券交易所代码:LITB)和Chindata Group Holdings Limited(NASDAQ:CD)的董事,并担任Zall集团(02098.HK)董事会联席主席。在创立YHD.com之前,于博士从2006年到2007年担任Dell Inc.全球采购副总裁,从2004年到2006年担任Amazon.com全球供应链副总裁。在亚马逊之前,于博士从1989年到2004年担任the University of Texas at Austin McCombs School of Business的讲座教授。他于1982年获得武汉大学理学学士学位,1986年获得Cornell University物理学硕士学位,1990年获得Wharton School of the University of Pennsylvania决策科学博士学位。于博士自2019年起担任the Wharton School of the University of Pennsylvania的监管委员会成员。于博士出版了6本专著和80多篇期刊文章。于博士还持有三项与航空公司优化解决方案相关的美国专利。
Gang Yu,is 111, Inc. co-founder and has served as 111, Inc. executive chairman since 2015. Since September 2018, Dr. Yu has served as 111, Inc. co-chairman. He is a recipient of numerous prestigious international awards, including the 2002 Franz Edelman Management Science Achievement Award from INFORMS and the 2012 Martin K. Starr Excellence in Production and Operations Management Practice Award from POMS. Dr. Yu co-founded and served as chairman of YHD.com, a leading e-commerce company in China. Dr. Yu currently serves as a director of Midea Group Co., Ltd. (SZSE: 000333), LightInTheBox Holding Co., Ltd. (NYSE: LITB) and Chindata Group Holdings Limited (NASDAQ: CD), and as the co-chairman of the board of Zall Group (02098.HK). Prior to founding YHD.com, Dr. Yu served as the vice president of Worldwide Procurement at Dell Inc. from 2006 to 2007 and the vice president of Worldwide Supply Chain at Amazon.com from 2004 to 2006. Before Amazon, Dr. Yu was the chair professor at McCombs School of Business at The University of Texas at Austin from 1989 to 2004. Dr. Yu received his bachelor's degree in science from Wuhan University in 1982, master's degree in physics from Cornell University in 1986 and Ph.D. degree in decision sciences from The Wharton School of the University of Pennsylvania in 1990. Dr. Yu has been a member of the Board of Overseers of The Wharton School of the University of Pennsylvania since 2019. Dr. Yu has published 6 books and over 80 journal articles. Dr. Yu also holds three U.S. patents related to airline optimization solutions.
Nee Chuan Teo

Nee Chuan Teo,自2018年9月起担任111,Inc.独立董事。他是bioduro-sundia的首席财务官,bioduro-sundia是一家著名的公司,为其生物制药客户提供从早期药物发现到后期生产的单一端到端解决方案。在加入bioduro-sundia之前,他曾担任Huazhu Group Limited(China Lodging Group Limited,Nasdaq:HTHT)的首席财务官,这是中国领先的快速增长的多品牌酒店集团。2011年至2015年,他还担任Rnomac International Group(Volvo在中国最大的建筑设备分销商)的首席财务官;2007年至2009年担任分众传媒集团财务总监。他在英国Warwick University获得会计和财务分析学士学位。他是英国的特许注册会计师,美国和香港的注册会计师。


Nee Chuan Teo,has served as 111, Inc. independent director since September 2018. Mr. Teo is the chief financial officer of bioduro-sundia, a famous company providing its biopharma customers a single end-to-end solution from early stage drug discovery to late stage manufacturing. Prior to joining bioduro-sundia, Mr. Teo served as chief financial officer of Huazhu Group Limited (formerly China Lodging Group Limited, Nasdaq: HTHT), a leading fast-growing multi-brand hotel group in China from 2015 to 2021. He also served as chief financial officer of Rnomac International Group, the largest Volvo construction equipment distributor in China, from 2011 to 2015; and served as financial controller in Focus Media Group from 2007 to 2009. Mr. Teo received his bachelor of science in accounting and financial analysis from Warwick University, the United Kingdom. He is a chartered certified accountant in the United Kingdom and a certified public accountant in the United States and Hong Kong.
Nee Chuan Teo,自2018年9月起担任111,Inc.独立董事。他是bioduro-sundia的首席财务官,bioduro-sundia是一家著名的公司,为其生物制药客户提供从早期药物发现到后期生产的单一端到端解决方案。在加入bioduro-sundia之前,他曾担任Huazhu Group Limited(China Lodging Group Limited,Nasdaq:HTHT)的首席财务官,这是中国领先的快速增长的多品牌酒店集团。2011年至2015年,他还担任Rnomac International Group(Volvo在中国最大的建筑设备分销商)的首席财务官;2007年至2009年担任分众传媒集团财务总监。他在英国Warwick University获得会计和财务分析学士学位。他是英国的特许注册会计师,美国和香港的注册会计师。
Nee Chuan Teo,has served as 111, Inc. independent director since September 2018. Mr. Teo is the chief financial officer of bioduro-sundia, a famous company providing its biopharma customers a single end-to-end solution from early stage drug discovery to late stage manufacturing. Prior to joining bioduro-sundia, Mr. Teo served as chief financial officer of Huazhu Group Limited (formerly China Lodging Group Limited, Nasdaq: HTHT), a leading fast-growing multi-brand hotel group in China from 2015 to 2021. He also served as chief financial officer of Rnomac International Group, the largest Volvo construction equipment distributor in China, from 2011 to 2015; and served as financial controller in Focus Media Group from 2007 to 2009. Mr. Teo received his bachelor of science in accounting and financial analysis from Warwick University, the United Kingdom. He is a chartered certified accountant in the United Kingdom and a certified public accountant in the United States and Hong Kong.
Jian Sun

Jian Sun,自2018年9月起担任111,Inc.的独立董事。Sun先生是中国顶级旅游服务公司BTG酒店(集团)有限公司(上海证券交易所股票代码:600258)的执行董事兼总经理。在加入BTG酒店集团之前,Sun先生从2004年到2016年担任Home Inns Group(中国领先的经济型连锁酒店,此前在Nasdaq上市)的执行董事兼首席执行官。2014年以来,Sun先生担任Leju Holdings Limited(纽约证券交易所代码:Leju)的独立董事和薪酬委员会成员,这是中国领先的线上到线下房地产服务提供商。他持有中国上海医科大学的学士学位。


Jian Sun,has served as 111, Inc. independent director since September 2018. Mr. Sun is an executive director and the general manager of BTG Hotels (Group) Co., Ltd. (Shanghai Stock Exchange Stock Code: 600258), a top tourism service company in China. Prior to joining BTG Hotels Group, Mr. Sun served as executive director and chief executive officer of Home Inns Group, a leading economy hotel chain in China previously listed on Nasdaq, from 2004 to 2016. Since 2014, Mr. Sun has served as an independent director and a member of the compensation committee of Leju Holdings Limited (NYSE: LEJU), a leading online-to-offline real estate services provider in China. Mr. Sun holds a bachelor's degree from Shanghai Medical University in China.
Jian Sun,自2018年9月起担任111,Inc.的独立董事。Sun先生是中国顶级旅游服务公司BTG酒店(集团)有限公司(上海证券交易所股票代码:600258)的执行董事兼总经理。在加入BTG酒店集团之前,Sun先生从2004年到2016年担任Home Inns Group(中国领先的经济型连锁酒店,此前在Nasdaq上市)的执行董事兼首席执行官。2014年以来,Sun先生担任Leju Holdings Limited(纽约证券交易所代码:Leju)的独立董事和薪酬委员会成员,这是中国领先的线上到线下房地产服务提供商。他持有中国上海医科大学的学士学位。
Jian Sun,has served as 111, Inc. independent director since September 2018. Mr. Sun is an executive director and the general manager of BTG Hotels (Group) Co., Ltd. (Shanghai Stock Exchange Stock Code: 600258), a top tourism service company in China. Prior to joining BTG Hotels Group, Mr. Sun served as executive director and chief executive officer of Home Inns Group, a leading economy hotel chain in China previously listed on Nasdaq, from 2004 to 2016. Since 2014, Mr. Sun has served as an independent director and a member of the compensation committee of Leju Holdings Limited (NYSE: LEJU), a leading online-to-offline real estate services provider in China. Mr. Sun holds a bachelor's degree from Shanghai Medical University in China.
Leon Lian Yong Chen

Leon Lian Yong Chen,自2019年5月起担任111,Inc.董事。他目前是6 Dimensions Capital。的创始管理合伙人和首席执行官。他在中国和美国的生命科学行业拥有超过20年的经验,担任风险投资家、高级管理人员、企业家和科学发明家。2008年5月至2014年3月,他是Frontline BioVentures的创始人和管理合伙人,也是FIL Capital Management (Hong Kong) Limited在亚洲的合伙人。Chen博士自2018年5月起担任Ocumension Therapeutics的执行董事兼董事会主席,Ocumension Therapeutics是一家在证券交易所上市的公司(股票代码:1477)。自2018年8月至2021年7月,他担任CStone Pharmaceuticals(一家在联交所主板上市的公司)的董事(股票代码:2616)。2015年1月至2022年3月,他曾担任华医药(联交所主板上市公司)的非执行董事(股票代码:2552)。自2014年12月至2021年5月,他担任Shanghai Hile Bio-Pharmaceutical Co. Ltd.(上海证券交易所上市公司,股票代码:603718)的董事。除上述披露外,Lian Yong Chen博士在过去三年中不是也没有担任任何其他上市公司的董事。Lian Yong Chen博士于1991年7月在比利时University of Louvain获得化学博士学位后,在麻省理工学院进行博士后研究。他于1984年6月获得北京大学化学学士学位。


Leon Lian Yong Chen,has served as 111, Inc. director since May 2019. He is currently the founding managing partner and CEO of 6 Dimensions Capital. He has over 20 years of experience in the life sciences industry in China and the United States as a venture capitalist, senior management executive, entrepreneur, and scientific inventor. He was the founder and managing partner at Frontline BioVentures and a partner at FIL Capital Management (Hong Kong) Limited in Asia from May 2008 to March 2014. Dr. Chen has been an executive director and the chairman of the board of Ocumension Therapeutics since May 2018, a company listed on the Stock Exchange (stock code: 1477). Since August 2018 to July 2021, he has served as a director at CStone Pharmaceuticals, a company listed on the main board of the Stock Exchange (stock code: 2616). Since January 2015 to March 2022, he has served as a non-executive Director at Hua Medicine, a company listed on the main board of the Stock Exchange (stock code: 2552). He served as a director of Shanghai Hile Bio-Pharmaceutical Co. Ltd., a company listed on the Shanghai Stock Exchange (stock code: 603718) since December 2014 to May 2021. Save as disclosed above, Dr. Lian Yong Chen is not and has not been a director of any other listed companies in the past three years. Dr. Lian Yong Chen conducted postdoctoral research at the Massachusetts Institute of Technology after obtaining his Ph.D. degree in Chemistry (with top honor) from the University of Louvain, Louvain-La-Neuve in Belgium in July 1991. He obtained his Bachelor of Science degree in Chemistry from Peking University in June 1984.
Leon Lian Yong Chen,自2019年5月起担任111,Inc.董事。他目前是6 Dimensions Capital。的创始管理合伙人和首席执行官。他在中国和美国的生命科学行业拥有超过20年的经验,担任风险投资家、高级管理人员、企业家和科学发明家。2008年5月至2014年3月,他是Frontline BioVentures的创始人和管理合伙人,也是FIL Capital Management (Hong Kong) Limited在亚洲的合伙人。Chen博士自2018年5月起担任Ocumension Therapeutics的执行董事兼董事会主席,Ocumension Therapeutics是一家在证券交易所上市的公司(股票代码:1477)。自2018年8月至2021年7月,他担任CStone Pharmaceuticals(一家在联交所主板上市的公司)的董事(股票代码:2616)。2015年1月至2022年3月,他曾担任华医药(联交所主板上市公司)的非执行董事(股票代码:2552)。自2014年12月至2021年5月,他担任Shanghai Hile Bio-Pharmaceutical Co. Ltd.(上海证券交易所上市公司,股票代码:603718)的董事。除上述披露外,Lian Yong Chen博士在过去三年中不是也没有担任任何其他上市公司的董事。Lian Yong Chen博士于1991年7月在比利时University of Louvain获得化学博士学位后,在麻省理工学院进行博士后研究。他于1984年6月获得北京大学化学学士学位。
Leon Lian Yong Chen,has served as 111, Inc. director since May 2019. He is currently the founding managing partner and CEO of 6 Dimensions Capital. He has over 20 years of experience in the life sciences industry in China and the United States as a venture capitalist, senior management executive, entrepreneur, and scientific inventor. He was the founder and managing partner at Frontline BioVentures and a partner at FIL Capital Management (Hong Kong) Limited in Asia from May 2008 to March 2014. Dr. Chen has been an executive director and the chairman of the board of Ocumension Therapeutics since May 2018, a company listed on the Stock Exchange (stock code: 1477). Since August 2018 to July 2021, he has served as a director at CStone Pharmaceuticals, a company listed on the main board of the Stock Exchange (stock code: 2616). Since January 2015 to March 2022, he has served as a non-executive Director at Hua Medicine, a company listed on the main board of the Stock Exchange (stock code: 2552). He served as a director of Shanghai Hile Bio-Pharmaceutical Co. Ltd., a company listed on the Shanghai Stock Exchange (stock code: 603718) since December 2014 to May 2021. Save as disclosed above, Dr. Lian Yong Chen is not and has not been a director of any other listed companies in the past three years. Dr. Lian Yong Chen conducted postdoctoral research at the Massachusetts Institute of Technology after obtaining his Ph.D. degree in Chemistry (with top honor) from the University of Louvain, Louvain-La-Neuve in Belgium in July 1991. He obtained his Bachelor of Science degree in Chemistry from Peking University in June 1984.
Jun Luo

Jun Luo自2009年10月起担任CRIC联合总裁。Luo自2007年12月起担任Shanghai SINA Leju总经理。加入SINA之前,Luo从2006年4月到2007年11月担任Cisco Systems (China) Networking Technology Co., Ltd.大中华地区统一通信业务主管。2004年9月到2006年4月他担任Avaya (China) Communication Co. Ltd.应用业务主管和全国指定账户业务主管。Luo从2000年2月到2004年9月担任Cisco Systems (China) Networking Tech Co., Ltd.业务开发经理;1996年9月到2000年2月担任Oracle Software System Co., Ltd.销售经理。Luo持有Shanghai University of Finance and Economics学士学位。2010年获北京航空航天大学软件工程硕士学位。


Jun Luo,has served as 111, Inc. independent director since September 2018. Mr. Luo is the co-founder and chief executive officer of Tujia & Sweetome Group, a leading short-term property rental firm in China. Prior to co-founding Tujia & Sweetome Group, Mr. Luo served as general manager of Shanghai SINA Leju and executive president at China Real Estate Information Corporation. Mr. Luo received his bachelor's degree in accounting from Shanghai University of Finance and Economics in 1994 and master's degree in software engineering from Beihang University in China in 2010.
Jun Luo自2009年10月起担任CRIC联合总裁。Luo自2007年12月起担任Shanghai SINA Leju总经理。加入SINA之前,Luo从2006年4月到2007年11月担任Cisco Systems (China) Networking Technology Co., Ltd.大中华地区统一通信业务主管。2004年9月到2006年4月他担任Avaya (China) Communication Co. Ltd.应用业务主管和全国指定账户业务主管。Luo从2000年2月到2004年9月担任Cisco Systems (China) Networking Tech Co., Ltd.业务开发经理;1996年9月到2000年2月担任Oracle Software System Co., Ltd.销售经理。Luo持有Shanghai University of Finance and Economics学士学位。2010年获北京航空航天大学软件工程硕士学位。
Jun Luo,has served as 111, Inc. independent director since September 2018. Mr. Luo is the co-founder and chief executive officer of Tujia & Sweetome Group, a leading short-term property rental firm in China. Prior to co-founding Tujia & Sweetome Group, Mr. Luo served as general manager of Shanghai SINA Leju and executive president at China Real Estate Information Corporation. Mr. Luo received his bachelor's degree in accounting from Shanghai University of Finance and Economics in 1994 and master's degree in software engineering from Beihang University in China in 2010.

高管简历

中英对照 |  中文 |  英文
刘峻岭

刘峻岭先生,自2015年1月起担任汽车之家独立董事。刘先生是1号店的共同创始人和首席执行官,一个领先的在线食品杂货零售商在中国。在建立1号店2008刘先生是戴尔中国大陆和香港的联席总裁。在这之前,他是Avaya中国董事总经理。刘先生收到他的硕士学位,澳大利亚佛林德斯大学国际工商管理。刘峻岭先生,于2018年9月14日获委任为华领医药独立非执行董事。


Junling Liu,has served as Autohome Inc. independent director since January 2015. Mr. Liu is the co-founder, chairman and chief executive officer of 111, Inc. (Nasdaq: YI), an online healthcare cloud service provider. He co-founded and served as chief executive officer of YHD.com from 2008 to 2015. Prior to founding YHD.com, Mr. Liu served as the global vice president and president for mainland China and Hong Kong at Dell Inc. from 2006 to 2007. He also held various executive positions at internationally renowned technology companies such as Avaya (China) Communication Co., Ltd. Mr. Liu received his bachelor's degree in education from Flinders University in Australia and master's degree in international business administration from Flinders University.
刘峻岭先生,自2015年1月起担任汽车之家独立董事。刘先生是1号店的共同创始人和首席执行官,一个领先的在线食品杂货零售商在中国。在建立1号店2008刘先生是戴尔中国大陆和香港的联席总裁。在这之前,他是Avaya中国董事总经理。刘先生收到他的硕士学位,澳大利亚佛林德斯大学国际工商管理。刘峻岭先生,于2018年9月14日获委任为华领医药独立非执行董事。
Junling Liu,has served as Autohome Inc. independent director since January 2015. Mr. Liu is the co-founder, chairman and chief executive officer of 111, Inc. (Nasdaq: YI), an online healthcare cloud service provider. He co-founded and served as chief executive officer of YHD.com from 2008 to 2015. Prior to founding YHD.com, Mr. Liu served as the global vice president and president for mainland China and Hong Kong at Dell Inc. from 2006 to 2007. He also held various executive positions at internationally renowned technology companies such as Avaya (China) Communication Co., Ltd. Mr. Liu received his bachelor's degree in education from Flinders University in Australia and master's degree in international business administration from Flinders University.